Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes?

Overview of attention for article published in International Journal of Molecular Sciences, September 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,986 followers.

RT @Melanoma_MRV: Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes? ht…

Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes? https://t.co/aC2uNg0vzn #mdpiijms via @IJMS_MDPI

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.